[Epidemiology, clinical aspects and therapy of toxoplasmosis].
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D002648:Child; D003168:Complement Fixation Tests; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007244:Infectious Mononucleosis / Q000175:diagnosis; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000453:epidemiology; D011739:Pyrimethamine / Q000008:administration & dosage; D012698:Serologic Tests; D012882:Skin Tests; D013411:Sulfadiazine / Q000008:administration & dosage; D013607:Tablets; D014122:Toxoplasma / Q000302:isolation & purification; D014123:Toxoplasmosis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000453:epidemiology; D015047:Zoonoses
D013607:Tablets; D013411:Sulfadiazine; D011739:Pyrimethamine
Epidemiologie, Klinik und Therapie der Toxoplasmose.